Development and Characterization of a Semi-Solid Dosage Form of Meglumine Antimoniate for Topical Treatment of Cutaneous Leishmaniasis

Cutaneous leishmaniasis (CL) is treated with painful intralesional injections of meglumine antimoniate (MA). With the aim of developing an alternative topical treatment for CL, a gel-based formulation with 30% MA was prepared and its physicochemical properties, stability and rheological behavior wer...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pharmaceutics
Autors principals: Berenguer, Diana, Sosa, Lilian, Alcover, Magdalena, Sessa, Marcella, Halbaut, Lyda, Guillén, Carme, Fisa, Roser, Calpena-Campmany, Ana Cristina, Riera, Cristina
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6920791/
https://ncbi.nlm.nih.gov/pubmed/31731660
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics11110613
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars